Bridgefront Capital’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-21,938
Closed -$177K 430
2023
Q1
$177K Buy
+21,938
New +$177K 0.11% 356